Clinical Oncology - Issue 1/2024
Editorial
Original Articles
34
Evaluation pattern within tumor microenvironment and consequent gene expression in oral cancer
A. Vasheghani Farahani, M. Kavousi, F. Jamshidian
40
Analysis of the effect of baseline detection and early clearance of ct-DNA, on survival outcomes among patients with advanced EGFR-mutant non-small cell lung cancer
A. Joel, R. Abarna, R. T. Chacko, A. Singh, J. T. Georgy, A. O. John, D. B. Thumaty, S. Balukrishna, R. Isiah, S. Paavamani, T. A. Kodiatte, S. Rima, G. Rebekah, R. Pai
50
Immunohistochemical analysis of CD9, CD29 and epithelial to mesenchymal transition in triple-negative breast cancer
R.- Ondruššek, S. Brychtová, M. Bezděková, K. Bouchalova, Z. Vávrová, K. Souček, J. Bouchal
57
Klinická zkušenost s kabozantinibem u pacientů s metastatickým karcinomem ledviny
I. Richter, D. Šustrová, A. Vojkůvková, S. Al-Samsam, J. Bartoš, Jan Dvořák, T. Büchler
Reviews
10
Cardiac conduction system as a new organ at risk in radiotherapy
M. Domanský, J. Kubeš
20
Gut microbiome and pancreatic cancer
M. Eid, Arnošt Martínek, Jiří Dolina, Magdalena Uvírová, Petr Dítě
27
Molecular basis of multiple myeloma
D. Nižňanská, M. Vlachová, J. Gregorová, J. Kotašková, M. Jarošová, S. Ševčíková
Short Communication
63
Treatment of tobacco dependence in cancer patients - Recommendations of the Section of Supportive Treatment and Care and the Section of Preventive Oncology of the Czech Cancer Society of the Czech Medical Association of J. E. Purkyně, Working Group for the Prevention and Treatment of Tobacco Dependence of the Czech Medical Association of J. E. Purkyně, and the Society for Treatment of Tobacco Dependence
K. Zvolská, E. Králíková, S. Vokurka, J. Halámková, A. Strnadová
Personal News
Clinical Oncology
2024 Issue 1
Most read in this issue
- Molecular basis of multiple myeloma
- Gut microbiome and pancreatic cancer
- Pokročilé léčebné strategie metastatického kolorektálního karcinomu a karcinomu pankreatu
- Analysis of the effect of baseline detection and early clearance of ct-DNA, on survival outcomes among patients with advanced EGFR-mutant non-small cell lung cancer